Tag: TCT 2025
Enrolment in SPIRARE II pivotal trial of embolectomy system for pulmonary...
Jupiter Endovascular today announced completion of patient enrolment in the SPIRARE II pivotal trial evaluating the Vertex pulmonary embolectomy system in patients with acute,...
Interim results of covered stent-graft hint at “new avenue” in dialysis...
The interim results of a first-in-human trial of a sirolimus-eluting covered stent graft—Solaris DE (Solaris Endovascular)—for the treatment of dialysis access dysfunction demonstrate the...
Results from sex-specific analysis of Surmodics’ PROWL registry revealed
Surmodics has announced that results from a sex-specific analysis of 160 real-world acute, subacute, and chronic thrombotic limb ischaemia patients from its PROWL registry...
Interim RAPID-PE study reveals “excellent” safety data in first 50 patients
Prespecified interim analysis data from the first 50 patients in RAPID-PE have demonstrated "excellent safety" and "remarkably efficient lab times" in patients receiving on-the-table...
STORM-PE finds mechanical thrombectomy superior to anticoagulation alone
The use of mechanical thrombectomy, specifically computer-assisted vacuum thrombectomy (CAVT) using the 16Fr Lightning Flash system (Penumbra), with anticoagulation achieves superior reduction in right...
Three-year results demonstrate “durable” impact of radiofrequency renal denervation
Medtronic has announced new, long-term results from its final report of the SPYRAL HTN-ON MED randomised clinical trial, showing that patients treated with the...
